OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
3
Results
Show all
Save search
Copy query
Show results for
Unknown
(3)
Publication Date
Release Date
2023
(3)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Optimized dithranol-imiquimod-based transcutaneous immunization enables tumor rejection.
Not available
S-EPMC10505723
|
biostudies-literature
Cite
Quality by Design (QbD) Approach for a Nanoparticulate Imiquimod Formulation as an Investigational Medicinal Product.
Not available
S-EPMC9965879
|
biostudies-literature
Cite
Tumor-infiltrating CCR2
+
inflammatory monocytes counteract specific immunotherapy.
Not available
S-EPMC10577317
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
